The c-jun kinase/stress-activated pathway: Regulation, function and role in human disease
Top Cited Papers
- 4 January 2007
- journal article
- review article
- Published by Elsevier
- Vol. 1773 (8) , 1341-1348
- https://doi.org/10.1016/j.bbamcr.2006.12.009
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activationProceedings of the National Academy of Sciences, 2006
- Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brainsNeuroscience Letters, 2006
- Cochlear implantation trauma and noise‐induced hearing loss: Apoptosis and therapeutic strategiesThe Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 2006
- MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expressionCurrent Opinion in Chemical Biology, 2005
- Therapeutic promise of JNK ATP-noncompetitive inhibitorsTrends in Molecular Medicine, 2005
- JNK mediates hepatic ischemia reperfusion injuryJournal of Hepatology, 2005
- Inhibition of c‐Jun N‐terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized ratsBritish Journal of Pharmacology, 2004
- Use of cell-permeable peptides to prevent neuronal degenerationTrends in Molecular Medicine, 2004
- Aberrant Tau Phosphorylation by Glycogen Synthase Kinase-3β and JNK3 Induces Oligomeric Tau Fibrils in COS-7 CellsJournal of Biological Chemistry, 2002
- AP-1 in cell proliferation and survivalOncogene, 2001